Cellectar Biosciences
CLRB
CLRB
35 hedge funds and large institutions have $30M invested in Cellectar Biosciences in 2024 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 9 increasing their positions, 10 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
5% less funds holding
Funds holding: 37 → 35 (-2)
10% less repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 10
29% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 7
Holders
35
Holding in Top 10
2
Calls
$184K
Puts
$81K
Top Buyers
| 1 | +$2.07M | |
| 2 | +$1.88M | |
| 3 | +$728K | |
| 4 |
ACM
Altium Capital Management
New York
|
+$460K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$349K |
Top Sellers
| 1 | -$375K | |
| 2 | -$176K | |
| 3 | -$111K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$108K |
| 5 |
Millennium Management
New York
|
-$107K |